sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
Published 1 year ago • 165 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
0:45
bispecific car t-cell therapy: combining anti-cd19 and cd22 car t-cells
-
1:50
outcomes of patients with dlbcl following asct and/or car-t
-
2:22
combining car-ts & bispecific antibodies
-
2:29
emerging lymphoma therapies: bispecific antibodies and car t-cells
-
1:37
the use of bispecifics and car t-cells in south america: challenges that remain
-
2:37
efficacy of bispecific cd19/cd22 car t-cells in b-cell malignancies
-
1:06
how will novel agents & car-t cells affect the future treatment landscape in b-all?
-
1:02
the use of car-t cell products in a real-world setting
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
12:59
advances in car-t cell therapy - creative biolabs
-
5:04
dlbcl and car t cell therapy - kim's lymphoma story
-
2:48
outcomes of autosct, allosct & car-t cell therapy in patients with tp53-altered mcl
-
1:55
developing the next generation of car-t cells
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
0:44
the role of allosct for r/r lbcl in the era of car-t therapy
-
1:39
the role of myeloid cells in car-t cell therapy
-
1:56
advances in off-the-shelf third-party t-cells for the treatment of infectious diseases post-bmt
-
8:57
outcomes of sct in t-all and t-lbl
-
1:19
the future of car t-cell therapy in b-cell malignancies
-
1:26
impact of recent bendamustine treatment before apheresis on car-t therapy outcomes in lbcl
-
1:26
the safety and efficacy of allosct following car-t cell therapy for large b-cell lymphoma
-
1:05
t-cell evolution in aml and its impact on the efficacy of bispecific antibodies